The U.S. Food and Drug Administration granted Marketing Granted Orders for 11 ZYN ULTRA moist oral nicotine pouch products sold by Philip Morris International's affiliate Swedish Match USA. Philip Morris International shares trade at US$188.23, down 3.12% over the past 30 days but up 17.42% year to date and 132.88% over five years. The most widely followed fair value estimate of $203.80 implies the stock is 7.6% undervalued, supported by double-digit volume and margin growth in IQOS, ZYN, and VEEV platforms. Risks include structural declines in cigarette volumes and potential regulatory or tax changes.
Philip Morris International IncFDA granted Marketing Granted Orders for 11 ZYN ULTRA products, a regulatory approval that expands its product portfolio.
